The FTIR has a detection limit of approximately 5%. Substances below this level may not appear in results — even if they are toxic or affect the potency of your sample.
When possible, we may provide a percentage estimate based on what the FTIR detects. These numbers are generated by software and reflect only the visible components — not the full composition of the sample. The FTIR cannot isolate individual substances in complex mixtures, so any percentage estimates are approximate. They may not reflect actual potency, and similar-looking samples can yield different results – therefore our results are not suitable for purity testing.
Undetected ingredients below the detection threshold may influence the composition. Any percentages listed intended only as a general indication of how the identified ingredients are distributed within the sample. Due to this, our results should not be used to determine exact dosages.
Additionally, a sample may not reflect the full composition of a drug. For example, testing a portion of a pill may not represent the rest of the pill, or other pills from the same batch. Cross-contamination between samples stored together can also affect results.
When we detect only one substance, we don’t provide a percentage because other ingredients might still be present below the 5% detection limit.
Treat any percentage result as a rough guideline, not a precise measurement.
Tests highlighted in red indicate particularly dangerous or unexpected results. Flagged samples can alslo be viewed on our Alerts page.
We also use test strips to detect the presence of fentanyl, benzodiazapenes, and lysergamide (LSD).
The uncertain match in this sample shares similarities with several other 5 MeO substances and therefore could not be definitively identified to be one specific 5 MeO substance.
GBL is a prodrug of GHB and is converted into GHB in the human body via lactonase enzymes in the blood. GBL is more fat-soluble than GHB and therefore is more readily absorbed which could make the effects more potent than GHB. A user may want to consider starting at a smaller dose and waiting longer prior to re-dosing.
Etizolam is a thienodiazepine which is similar to the benzodiazepine drug class. It has effects that depress the central nervous system, these include sedation and skeletal muscular relaxation. Etizolam does not trigger the benzodiazepine test strips making it difficult to detect since it is potent at such low concentrations. Our understanding is that etizolam has a faster onset and cessation of effects than alprazolam with a similar potency.
Vancouver, BC
08/18/2024
Category: Unknown White Powder Code: potato-beige
Unknown
Bromazolam
Fentanyl: Positive Benzodiazepine: Positive
Vancouver, BC
08/18/2024
Category: Unknown Pink Chunk
Unknown
Microcrystalline Cellulose
30-35%
Caffeine
30-35%
MDA
20-25%
Uncertain Oil
5-10%
Fentanyl: Negative Benzodiazepine: Negative
Vancouver, BC
08/18/2024
Category: Unknown White Powder
Unknown
MDMA
Fentanyl: Negative Benzodiazepine: Negative
Vancouver, BC
08/18/2024
Category: Unknown White Powder Code: potato-white
Unknown
Caffeine
90-95%
Uncertain Match
5-10%
Fentanyl: Negative Benzodiazepine: Positive
The uncertain match shared similarities with several other benzodiazepines.
Vancouver, BC
08/18/2024
Category: Other Red Chunk
Tadalafil
Microcrystalline Cellulose
45-50%
Tadalafil
15-20%
Calcium Stearate
15-20%
Uncertain Carbohydrate
10-15%
Uncertain Mineral
5-10%
Fentanyl: Negative
Vancouver, BC
08/18/2024
Category: Opioid Dark Brown Paste
Opium
Opium
N/A
Uncertain Carbohydrate
N/A
Uncertain Mineral
N/A
Fentanyl: Negative
Vancouver, BC
08/17/2024
Category: Unknown Light Yellow Powder
Unknown
Cocaine
30-35%
Ketamine
25-30%
MDMA
15-20%
MDA
5-10%
Uncertain Match
5-10%
Fentanyl: Negative Benzodiazepine: Negative
This sample was very complex, the uncertain match may contain another active ingredient but could not be confirmed